Enalapril más Carvedilol en la prevención de la cardiotoxicidad por antraciclinas y/o trastuzumab
Introduction: Chemotherapy cardiotoxicity affects quality of life and survival in cancer patients. Objective: To evaluate the effectiveness of enalapril plus carvedilol in the prevention of cardiotoxicity in patients with cancer treated with anthracyclines and / or trastuzumab. Method: A descriptive...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=8101387 |
| Tags: |
No Tags, Be the first to tag this record!
|